E-commerce Contacto
/contact

Hawes, Endosonografía 4 edición

Robert H. Hawes


  1. Sección IV: Páncreas y árbol biliar
  2. Cap. 15 Ultrasonido endoscópico en la evaluación de los quistes pancreáticos
Regresar

Capítulo 15 Ultrasonido endoscópico en la evaluación de los quistes pancreáticos.

  1. Laffan TA, Horton KM, Klein APet al., et al. Prevalence of unsuspected pancreatic cysts on MDCT. AJR Am J Roentgenol. 2008;191:802–807.
  2. Lee KS, Sekhar A, Rofsky NMet al., et al. Prevalence of incidental pancreatic cysts in the adult population on MR imaging. Am J Gastroenterol. 2010;105:2079–2084.
  3. Jones MJ, Buchanan AS, Neal CPet al., et al. Imaging of indeterminate pancreatic cystic lesions: a systematic review. Pancreatology. 2013;13:436–442.
  4. Valsangkar NP, Morales-Oyarvide V, Thayer SPet al., et al. 851 resected cystic tumors of the pancreas: a 33-year experience at the Massachusetts General Hospital. Surgery. 2012;152:S4–S12.
  5. Lennon AM, Manos LL, Hruban RHet al., et al. Role of a multidisciplinary clinic in the management of patients with pancreatic cysts: a single-center cohort study. Ann Surg Oncol. 2014;21:3668–3674.
  6. Shin EJ, Canto MI. Pancreatic cancer screening. Gastroenterol Clin North Am. 2012;41:143–157.
  7. Anand N, Sampath K, Wu BU. Cyst features and risk of malignancy in intraductal papillary mucinous neoplasms of the pancreas: a meta-analysis. Clin Gastroenterol Hepatol. 2013;11:913–921. quiz e59–e60.
  8. Thomas T, Bebb J, Mannath Jet al., et al. EUS-guided pancreatic cyst brushing: a comparative study in a tertiary referral centre. JOP. 2010;11:163–169.
  9. Ohno E, Hirooka Y, Itoh Aet al., et al. Intraductal papillary mucinous neoplasms of the pancreas: differentiation of malignant and benign tumors by endoscopic ultrasound findings of mural nodules. Ann Surg. 2009;249:628–634.
  10. Kurihara N, Kawamoto H, Kobayashi Yet al., et al. Vascular patterns in nodules of intraductal papillary mucinous neoplasms depicted under contrast-enhanced ultrasonography are helpful for evaluating malignant potential. Eur J Radiol. 2012;81:66–70.
  11. Wang KX, Ben QW, Jin ZDet al., et al. Assessment of morbidity and mortality associated with EUS-guided FNA: a systematic review. Gastrointest Endosc. 2011;73:283–290.
  12. Matsumoto K, Katanuma A, Maguchi Het al., et al. Performance of novel tissue harmonic echo imaging using endoscopic ultrasound for pancreatic diseases. Endosc Int Open. 2016;4:E42–50.
  13. Law JK, Wolfgang CL, Weiss MJet al., et al. Concomitant pancreatic adenocarcinoma in a patient with branch-duct intraductal papillary mucinous neoplasm. World J Gastroenterol. 2014;20:9200–9204.
  14. Neumann H, Kiesslich R, Wallace MBet al., et al. Confocal laser endomicroscopy: technical advances and clinical applications. Gastroenterology. 2010;139:388–392. 392 e1–2.
  15. Konda VJ, Meining A, Jamil LHet al., et al. A pilot study of in vivo identification of pancreatic cystic neoplasms with needle-based confocal laser endomicroscopy under endosonographic guidance. Endoscopy. 2013;45:1006–1013.
  16. Napoleon B, Lemaistre AI, Pujol Bet al., et al. A novel approach to the diagnosis of pancreatic serous cystadenoma: needle-based confocal laser endomicroscopy. Endoscopy. 2015;47:26–32.
  17. Nakai Y, Iwashita T, Park DHet al., et al. Diagnosis of pancreatic cysts: EUS-guided, through-the-needle confocal laser-induced endomicroscopy and cystoscopy trial: DETECT study. Gastrointest Endosc. 2015;81:1204–1214.
  18. Brugge WR, Lewandrowski K, Lee-Lewandrowski Eet al., et al. Diagnosis of pancreatic cystic neoplasms: a report of the cooperative pancreatic cyst study. Gastroenterology. 2004;126:1330–1336.
  19. de Jong K, van Hooft JE, Nio CYet al., et al. Accuracy of preoperative workup in a prospective series of surgically resected cystic pancreatic lesions. Scand J Gastroenterol. 2012;47:1056–1063.
  20. Sedlack R, Affi A, Vazquez-Sequeiros Eet al., et al. Utility of EUS in the evaluation of cystic pancreatic lesions. Gastrointest Endosc. 2002;56:543–547.
  21. Hong SK, Loren DE, Rogart JNet al., et al. Targeted cyst wall puncture and aspiration during EUS-FNA increases the diagnostic yield of premalignant and malignant pancreatic cysts. Gastrointest Endosc. 2012;75:775–782.
  22. Sendino O, Fernandez-Esparrach G, Sole Met al., et al. Endoscopic ultrasonography-guided brushing increases cellular diagnosis of pancreatic cysts: a prospective study. Dig Liver Dis. 2010;42:877–881.
  23. Al-Haddad M, Gill KR, Raimondo Met al., et al. Safety and efficacy of cytology brushings versus standard fine-needle aspiration in evaluating cystic pancreatic lesions: a controlled study. Endoscopy. 2010;42:127–132.
  24. ASGE Standards Of Practice C, Banerjee S, Shen Bet al., et al. Antibiotic prophylaxis for GI endoscopy. Gastrointest Endosc. 2008;67:791–798.
  25. Yoon WJ, Daglilar ES, Fernandez-del Castillo Cet al., et al. Peritoneal seeding in intraductal papillary mucinous neoplasm of the pancreas patients who underwent endoscopic ultrasound-guided fine-needle aspiration: the PIPE Study. Endoscopy. 2014;46:382–387.
  26. Bick BL, Enders FT, Levy MJet al., et al. The string sign for diagnosis of mucinous pancreatic cysts. Endoscopy. 2015;47:626–631.
  27. Brandwein SL, Farrell JJ, Centeno BAet al., et al. Detection and tumor staging of malignancy in cystic, intraductal, and solid tumors of the pancreas by EUS. Gastrointest Endosc. 2001;53:722–727.
  28. Hernandez LV, Mishra G, Forsmark Cet al., et al. Role of endoscopic ultrasound (EUS) and EUS-guided fine needle aspiration in the diagnosis and treatment of cystic lesions of the pancreas. Pancreas. 2002;25:222–228.
  29. Frossard JL, Amouyal P, Amouyal Get al., et al. Performance of endosonography-guided fine needle aspiration and biopsy in the diagnosis of pancreatic cystic lesions. Am J Gastroenterol. 2003;98:1516–1524.
  30. Olson MT, Ali SZ. Cytotechnologist on-site evaluation of pancreas fine needle aspiration adequacy: comparison with cytopathologists and correlation with the final interpretation. Acta Cytol. 2012;56:340–346.
  31. Maire F, Couvelard A, Hammel Pet al., et al. Intraductal papillary mucinous tumors of the pancreas: the preoperative value of cytologic and histopathologic diagnosis. Gastrointest Endosc. 2003;58:701–706.
  32. Lai R, Stanley MW, Bardales Ret al., et al. Endoscopic ultrasound-guided pancreatic duct aspiration: diagnostic yield and safety. Endoscopy. 2002;34:715–720.
  33. Thornton GD, McPhail MJ, Nayagam Set al., et al. Endoscopic ultrasound guided fine needle aspiration for the diagnosis of pancreatic cystic neoplasms: a meta-analysis. Pancreatology. 2013;13:48–57.
  34. Cizginer S, Turner BG, Bilge ARet al., et al. Cyst fluid carcinoembryonic antigen is an accurate diagnostic marker of pancreatic mucinous cysts. Pancreas. 2011;40:1024–1028.
  35. Hammel P, Voitot H, Vilgrain Vet al., et al. Diagnostic value of CA 72-4 and carcinoembryonic antigen determination in the fluid of pancreatic cystic lesions. Eur J Gastroenterol Hepatol. 1998;10:345–348.
  36. Park WG, Mascarenhas R, Palaez-Luna Met al., et al. Diagnostic performance of cyst fluid carcinoembryonic antigen and amylase in histologically confirmed pancreatic cysts. Pancreas. 2011;40:42–45.
  37. Al-Rashdan A, Schmidt CM, Al-Haddad Met al., et al. Fluid analysis prior to surgical resection of suspected mucinous pancreatic cysts. A single centre experience. J Gastrointest Oncol. 2011;2:208–214.
  38. van der Waaij LA, van Dullemen HM, Porte RJ. Cyst fluid analysis in the differential diagnosis of pancreatic cystic lesions: a pooled analysis. Gastrointest Endosc. 2005;62:383–389.
  39. Wu J, Jiao Y, Dal Molin Met al., et al. Whole-exome sequencing of neoplastic cysts of the pancreas reveals recurrent mutations in components of ubiquitin-dependent pathways. Proc Natl Acad Sci U S A. 2011;108:21188–21193.
  40. Springer S, Wang Y, Dal Molin Met al., et al. A combination of molecular markers and clinical features improve the classification of pancreatic cysts. Gastroenterology. 2015;149:1501–1510.
  41. Singhi AD, Zeh HJ, Brand REet al., et al. American gastroenterological association guidelines are inaccurate in detecting pancreatic cysts with advanced neoplasia: a clinicopathologic study of 225 patients with supporting molecular data. Gastrointest Endosc. 2016;83:1107–1117. e2.
  42. Wu J, Matthaei H, Maitra Aet al., et al. Recurrent GNAS mutations define an unexpected pathway for pancreatic cyst development. Sci Transl Med. 2011;3. 92ra66.
  43. Sakorafas GH, Smyrniotis V, Reid-Lombardo KMet al., et al. Primary pancreatic cystic neoplasms of the pancreas revisited. Part IV: rare cystic neoplasms. Surg Oncol. 2012;21:153–163.
  44. Khashab MA, Shin EJ, Amateau Set al., et al. Tumor size and location correlate with behavior of pancreatic serous cystic neoplasms. Am J Gastroenterol. 2011;106:1521–1526.
  45. Kimura W, Moriya T, Hanada Ket al., et al. Multicenter study of serous cystic neoplasm of the Japan pancreas society. Pancreas. 2012;41:380–387.
  46. Jaïs B, Rebours V, Malleo Get al., et al. Pancreatic serous cystadenoma related mortality is nil. Results of a multinational study under the auspices of the International Association of Pancreatology and the European Pancreatic Club. Gut. 2015. [Epub ahead of print].
  47. Jais B, Rebours V, Malleo Get al., et al. Serous cystic neoplasm of the pancreas: a multinational study of 2622 patients under the auspices of the International Association of Pancreatology and European Pancreatic Club (European Study Group on Cystic Tumors of the Pancreas). Gut. 2016;65:305–312.
  48. Yamao K, Yanagisawa A, Takahashi Ket al., et al. Clinicopathological features and prognosis of mucinous cystic neoplasm with ovarian-type stroma: a multi-institutional study of the Japan pancreas society. Pancreas. 2011;40:67–71.
  49. Reddy RP, Smyrk TC, Zapiach Met al., et al. Pancreatic mucinous cystic neoplasm defined by ovarian stroma: demographics, clinical features, and prevalence of cancer. Clin Gastroenterol Hepatol. 2004;2:1026–1031.
  50. Nilsson LN, Keane MG, Shamali Aet al., et al. Nature and management of pancreatic mucinous cystic neoplasm (MCN): a systematic review of the literature. Pancreatology. 2016;16:1028–1036.
  51. Baker ML, Seeley ES, Pai Ret al., et al. Invasive mucinous cystic neoplasms of the pancreas. Exp Mol Pathol. 2012;93:345–349.
  52. Tanaka M, Fernandez-Del Castillo C, Adsay Vet al., et al. International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. Pancreatology. 2012;12:183–197.
  53. Del Chiaro M, Verbeke C, Salvia Ret al., et al. European experts consensus statement on cystic tumours of the pancreas. Dig Liver Dis. 2013;45:703–711.
  54. Vege SS, Ziring B, Jain Ret al., et al. American gastroenterological association institute guideline on the diagnosis and management of asymptomatic neoplastic pancreatic cysts. Gastroenterology. 2015;148:819–822.
  55. Khalid A, Brugge W. ACG practice guidelines for the diagnosis and management of neoplastic pancreatic cysts. Am J Gastroenterol. 2007;102:2339–2349.
  56. Ohtsuka T, Kono H, Tanabe Ret al., et al. Follow-up study after resection of intraductal papillary mucinous neoplasm of the pancreas; special references to the multifocal lesions and development of ductal carcinoma in the remnant pancreas. Am J Surg. 2012;204:44–48.
  57. Mori Y, Ohtsuka T, Tsutsumi Ket al., et al. Multifocal pancreatic ductal adenocarcinomas concomitant with intraductal papillary mucinous neoplasms of the pancreas detected by intraoperative pancreatic juice cytology. A case report. JOP. 2010;11:389–392.
  58. Uehara H, Nakaizumi A, Ishikawa Oet al., et al. Development of ductal carcinoma of the pancreas during follow-up of branch duct intraductal papillary mucinous neoplasm of the pancreas. Gut. 2008;57:1561–1565.
  59. Kanno A, Satoh K, Hirota Met al., et al. Prediction of invasive carcinoma in branch type intraductal papillary mucinous neoplasms of the pancreas. J Gastroenterol. 2010;45:952–959.
  60. Singanayagam A, Manalan K, Sridhar Set al., et al. Evaluation of screening methods for identification of patients with chronic rheumatological disease requiring tuberculosis chemoprophylaxis prior to commencement of TNF-alpha antagonist therapy. Thorax. 2013;68:955–961.
  61. Ingkakul T, Sadakari Y, Ienaga Jet al., et al. Predictors of the presence of concomitant invasive ductal carcinoma in intraductal papillary mucinous neoplasm of the pancreas. Ann Surg. 2010;251:70–75.
  62. Furukawa T, Kloppel G, Volkan Adsay Net al., et al. Classification of types of intraductal papillary-mucinous neoplasm of the pancreas: a consensus study. Virchows Arch. 2005;447:794–799.
  63. Maker AV, Katabi N, Gonen Met al., et al. Pancreatic cyst fluid and serum mucin levels predict dysplasia in intraductal papillary mucinous neoplasms of the pancreas. Ann Surg Oncol. 2011;18:199–206.
  64. Lennon AM, Ahuja N, Wolfgang CL. AGA guidelines for the management of pancreatic cysts. Gastroenterology. 2015;149:825.
  65. Canto MI, Hruban RH. Managing pancreatic cysts: less is more? Gastroenterology. 2015;148:688–691.
  66. Fernandez-Del Castillo C, Tanaka M. Management of pancreatic cysts: the evidence is not here yet. Gastroenterology. 2015;148:685–687.
  67. Law JK, Ahmed A, Singh VKet al., et al. A systematic review of solid-pseudopapillary neoplasms: are these rare lesions? Pancreas. 2014;43:331–337.
  68. Law JK, Stoita A, Wever Wet al., et al. Endoscopic ultrasound-guided fine needle aspiration improves the pre-operative diagnostic yield of solid-pseudopapillary neoplasm of the pancreas: an international multicenter case series (with video). Surg Endosc. 2014;28:2592–2598.
  69. Kanda M, Knight S, Topazian MDet al., et al. Mutant GNAS detected in duodenal collections of secretin-stimulated pancreatic juice indicates the presence or emergence of pancreatic cysts. Gut. 2013;62:1024–1033.
  70. Gan SI, Thompson CC, Lauwers GYet al., et al. Ethanol lavage of pancreatic cystic lesions: initial pilot study. Gastrointest Endosc. 2005;61:746–752.
  71. Oh HC, Seo DW, Lee TYet al., et al. New treatment for cystic tumors of the pancreas: EUS-guided ethanol lavage with paclitaxel injection. Gastrointest Endosc. 2008;67:636–642.
  72. Oh HC, Seo DW, Kim SCet al., et al. Septated cystic tumors of the pancreas: is it possible to treat them by endoscopic ultrasonography-guided intervention? Scand J Gastroenterol. 2009;44:242–247.
  73. DeWitt J, McGreevy K, Schmidt CMet al., et al. EUS-guided ethanol versus saline solution lavage for pancreatic cysts: a randomized, double-blind study. Gastrointest Endosc. 2009;70:710–723.
  74. Oh HC, Seo DW, Song TJet al., et al. Endoscopic ultrasonography-guided ethanol lavage with paclitaxel injection treats patients with pancreatic cysts. Gastroenterology. 2011;140:172–179.
  75. DiMaio CJ, DeWitt JM, Brugge WR. Ablation of pancreatic cystic lesions: the use of multiple endoscopic ultrasound-guided ethanol lavage sessions. Pancreas. 2011;40:664–668.
  76. Moyer MT, Dye CE, Sharzehi Set al., et al. Is alcohol required for effective pancreatic cyst ablation? The prospective randomized CHARM trial pilot study. Endosc Int Open. 2016;4:E603–E607.
Regresar